Pleural Mesothelioma in the Era of Immunotherapy
Over the course of the last decade, immunotherapy has revolutionised the management of a great number of cancer types. The treatment of pleural mesothelioma, a rare and highly aggressive cancer, is also being transformed by immunotherapy. The recent combination of ipilimumab and nivolumab improved o...
Main Authors: | Mathieu Chevallier, Floryane Kim, Alex Friedlaender, Alfredo Addeo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-07-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.1177/11795549231178173 |
Similar Items
-
Systemic Treatments for Unresectable Pleural Mesothelioma: A Review of the Literature
by: Floryane Kim, et al.
Published: (2021-03-01) -
Systemic Treatments for Unresectable Pleural Mesothelioma: A Review of the Literature
by: Floryane Kim, et al.
Published: (2021-03-01) -
Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
by: Giulio Metro, et al.
Published: (2021-09-01) -
Management of stage III non-small-cell lung cancer: rays of hope
by: Floryane Kim, et al.
Published: (2024-02-01) -
Immunotherapy in Malignant Pleural Mesothelioma
by: Cornedine J. de Gooijer, et al.
Published: (2020-02-01)